209 related articles for article (PubMed ID: 15012878)
1. [Inotropic therapy in heart failure: general aspects and clinical results].
Manito N; Kaplinsky EJ; Pujol R
Med Clin (Barc); 2004 Feb; 122(7):269-74. PubMed ID: 15012878
[TBL] [Abstract][Full Text] [Related]
2. Outpatient parenteral inotropic therapy for advanced heart failure.
Young JB; Moen EK
J Heart Lung Transplant; 2000 Aug; 19(8 Suppl):S49-57. PubMed ID: 11016488
[TBL] [Abstract][Full Text] [Related]
3. Role of nonglycosidic inotropic agents: indications, ethics, and limitations.
Chatterjee K; De Marco T
Med Clin North Am; 2003 Mar; 87(2):391-418. PubMed ID: 12693731
[TBL] [Abstract][Full Text] [Related]
4. Parenteral inotropic support for advanced congestive heart failure.
Leier CV; Binkley PF
Prog Cardiovasc Dis; 1998; 41(3):207-24. PubMed ID: 9872607
[TBL] [Abstract][Full Text] [Related]
5. Classical inotropes and new cardiac enhancers.
Parissis JT; Farmakis D; Nieminen M
Heart Fail Rev; 2007 Jun; 12(2):149-56. PubMed ID: 17487580
[TBL] [Abstract][Full Text] [Related]
6. Palliative Inotropes in Advanced Heart Failure: Comparing Outcomes Between Milrinone and Dobutamine.
Sami F; Acharya P; Noonan G; Maurides S; Al-Masry AA; Bajwa S; Parimi N; Boda I; Tran C; Goyal A; Mastoris I; Dalia T; Sauer A; Bakel AV; Shah Z
J Card Fail; 2022 Dec; 28(12):1683-1691. PubMed ID: 36122816
[TBL] [Abstract][Full Text] [Related]
7. A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus.
Farmakis D; Agostoni P; Baholli L; Bautin A; Comin-Colet J; Crespo-Leiro MG; Fedele F; García-Pinilla JM; Giannakoulas G; Grigioni F; Gruchała M; Gustafsson F; Harjola VP; Hasin T; Herpain A; Iliodromitis EK; Karason K; Kivikko M; Liaudet L; Ljubas-Maček J; Marini M; Masip J; Mebazaa A; Nikolaou M; Ostadal P; Põder P; Pollesello P; Polyzogopoulou E; Pölzl G; Tschope C; Varpula M; von Lewinski D; Vrtovec B; Yilmaz MB; Zima E; Parissis J
Int J Cardiol; 2019 Dec; 297():83-90. PubMed ID: 31615650
[TBL] [Abstract][Full Text] [Related]
8. Do positive inotropic agents adversely affect the survival of patients with chronic congestive heart failure? III. Antagonist's viewpoint.
Colucci WS
J Am Coll Cardiol; 1988 Aug; 12(2):566-9. PubMed ID: 2899101
[No Abstract] [Full Text] [Related]
9. Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.
Aranda JM; Schofield RS; Pauly DF; Cleeton TS; Walker TC; Monroe VS; Leach D; Lopez LM; Hill JA
Am Heart J; 2003 Feb; 145(2):324-9. PubMed ID: 12595851
[TBL] [Abstract][Full Text] [Related]
10. Inotropic therapy for heart failure: an evidence-based approach.
Felker GM; O'Connor CM
Am Heart J; 2001 Sep; 142(3):393-401. PubMed ID: 11526351
[TBL] [Abstract][Full Text] [Related]
11. [Inotropic agents for treatment of acute heart failure syndromes in intensive care].
Rusca M; Liaudet L
Rev Med Suisse; 2009 Dec; 5(229):2512-5. PubMed ID: 20084871
[TBL] [Abstract][Full Text] [Related]
12. Calcium sensitizer agents: a new class of inotropic agents in the treatment of decompensated heart failure.
Perrone SV; Kaplinsky EJ
Int J Cardiol; 2005 Sep; 103(3):248-55. PubMed ID: 16098385
[TBL] [Abstract][Full Text] [Related]
13. Long-term intravenous inotropes in low-output terminal heart failure?
von Scheidt W; Pauschinger M; Ertl G
Clin Res Cardiol; 2016 Jun; 105(6):471-81. PubMed ID: 26879807
[TBL] [Abstract][Full Text] [Related]
14. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A
Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729
[TBL] [Abstract][Full Text] [Related]
15. Investigational positive inotropic agents for acute heart failure.
Tamargo J; Caballero R; Gómez R; Barana A; Amorós I; Delpón E
Cardiovasc Hematol Disord Drug Targets; 2009 Sep; 9(3):193-205. PubMed ID: 19534658
[TBL] [Abstract][Full Text] [Related]
16. A bridge for the 21st century in heart transplantation?
Felker GM; O'connor CM
Am Heart J; 2003 Feb; 145(2):198-9. PubMed ID: 12595831
[No Abstract] [Full Text] [Related]
17. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Positive Inotropic Agents in the Management of Acute Decompensated Heart Failure.
Kelly J; Cheng J; Malloy R; Lupi K
J Cardiovasc Pharmacol; 2020 May; 75(5):455-459. PubMed ID: 32091426
[TBL] [Abstract][Full Text] [Related]
19. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes.
Bayram M; De Luca L; Massie MB; Gheorghiade M
Am J Cardiol; 2005 Sep; 96(6A):47G-58G. PubMed ID: 16181823
[TBL] [Abstract][Full Text] [Related]
20. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
